YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Q2 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Earns Top Marks The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a look at how testing & diagnostics s…
Check out the companies making the biggest moves midday: Banks — The group fell, with pressure coming from longer-dated Treasury yields rising to levels not seen in 24 years. Shares of Citigroup , Wells Fargo and Goldman Sachs fell nearly…
Check out the companies making headlines before the bell: Neogen Corp – The food safety company jumped 11% after raising its fiscal year guidance. Neogen sees revenue ranging between $885 million and $890 million, versus its earlier call f…
NeoGenomics, Inc. recently amended its bylaws to expand its Board to up to eleven directors, issued preliminary third-quarter 2026 revenue guidance of about US$209 million with very strong next-generation sequencing growth, and outlined pl…
Stryker and Neogenomics stocks diverged Tuesday after the medtech companies announced their chief executives would soon step down. Continue Reading
Check out the companies making headlines before the bell: Constellation Energy , Alphabet — Alphabet shares rose about 0.5%, while Constellation Energy jumped more than 6%, after Google announced a major long-term power agreement with the…
Investing.com -- NeoGenomics Inc (NASDAQ:NEO) shares fell 3.6% in after-hours trading Monday following the company's announcement of a CEO transition, despite preliminary third quarter revenue results that exceeded analyst expectations. Be…
Gentherm Inc Combination Creates Global Market Leader of Thermal and Precision Flow Management Technologies Announces Appointment of Paul Mascarenas to its Board of Directors NOVI, Mich., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:…
An updated edition of the August 7, 2026 article. Women are taking on a growing role in corporate leadership, with more female executives guiding publicly traded companies across diverse industries. Their influence extends well beyond repr…
3 Healthcare Stocks We're Skeptical Of Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only risi…
Commercial production milestone and why it matters for Neo Performance Materials Neo Performance Materials (TSX:NEO) has moved its European permanent magnet plant into commercial production, now shipping rare earth sintered magnets to a Ti…
1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a c…
Trade threats between the U.S., Canada, and Europe are turning tariffs, minerals, and supply chains into tools of power, not just policy. That raises the stakes for any stock exposed to critical minerals and cross Atlantic trade flows. Mis…
Testing & Diagnostics Services Stocks Q2 Results: Benchmarking Guardant Health (NASDAQ:GH) Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at Guardant Health (NAS…
Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) offers broad healthcare exposure at a fraction of the cost, while First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) provides an aggressive, concentrated focus on biotechnology i…
An updated edition of the July 20, 2026, article. Genomics is a comprehensive study of genomes (an organism's complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this area have heightened interest from pharmaceutic…
Neo Performance Materials (TSX:NEO) has entered a new partnership with French rare earth technology company Carester SAS to support its European rare earth magnetics supply chain. The agreement covers long-term access to heavy rare earth m…
Greenland Mines Ltd At 2025 consumption levels, the NdPr oxide Sarfartoq is expected to produce annually from ST1 alone would represent approximately 34% of all NdPr oxide refined outside China Transaction closed September 1 following Gove…
Neo receives cash and shares of Greenland Mines, retaining an equity stake and offtake rights in the Sarfartoq Project. TORONTO, Sept. 2, 2026 /CNW/ -- Neo Performance Materials Inc. ("Neo" or the "Company") (TSX: NEO) (OTCQX: NOPMF) today…
NeoGenomics (NEO) is a leading cancer genetics diagnostics lab. Its stock recently hit a new 2-year high. Shares are up more than 170% over the past 52 weeks. NEO maintains a 100% "Buy" technical opinion from Barchart. Analyst sentiment is…
Shares of NeoGenomics (NEO) have been strong performers lately, with the stock up 22.3% over the past month. The stock hit a new 52-week high of $17.08 in the previous session. NeoGenomics has gained 44.4% since the start of the year compa…
3 Stocks Under $50 with Open Questions Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some…
3 Healthcare Stocks with Questionable Fundamentals From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial pe…
Shares of Illumina (ILMN) have been strong performers lately, with the stock up 8.7% over the past month. The stock hit a new 52-week high of $205.93 in the previous session. Illumina has gained 56.4% since the start of the year compared t…
3 of Wall Street's Favorite Stocks with Questionable Fundamentals Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it's worth remembering that analyst…
(RTTNews) - Today's top biotech gainers include SciSparc, after its subsidiary successfully completed internal validation of a proprietary quantum sampling platform designed to analyze clinical trial data; Avantor, following the release of…
[Wall Street New York City] aluxum/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-up moves before the bell on Wednesday. Stock index futures (SPX [https://seekingalpha.com/symbol/SPX]) were mostly higher on Wedne…
Earnings Call Insights: NeoGenomics (NEO) Q2 2026 MANAGEMENT VIEW * "We're raising guidance because of these results as well as the underlying clinical strength we're seeing in the back half of this year." (CEO Anthony Zook) * "Total reven…
Key Points Interested in NeoGenomics, Inc.? Here are five stocks we like better. NeoGenomics raised its 2026 outlook after Q2 revenue grew 11% year over year to $201.7 million, led by a 14% increase in clinical revenue. Full-year revenue g…
Key Points Vanguard Health Care ETF is significantly more affordable than First Trust NYSE Arca Biotechnology Index Fund while offering much broader exposure across the healthcare sector. First Trust NYSE Arca Biotechnology Index Fund has…
The First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) provides concentrated, high-conviction exposure to biotechnology firms, while the Vanguard Health Care ETF (NYSEMKT:VHT) offers a cheaper, diversified basket across the entir…
1 Momentum Stock with Solid Fundamentals and 2 We Avoid The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or…
iShares Global Healthcare ETF (NYSEMKT:IXJ) offers broad diversification across global healthcare sectors at a lower cost, while First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) provides a concentrated bet on biotechnology. Hea…
Key Points iShares Global Healthcare ETF provides broad exposure to 110 global stocks while First Trust NYSE Arca Biotechnology Index Fund concentrates on 30 biotech positions. iShares Global Healthcare ETF carries a lower expense ratio of…
Investors choosing between the State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) and First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) must weigh XLV's broad healthcare diversification and low cost against FBT's conc…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. NeoGenomics (NEO) drew fresh attention after announcing PTEN IHC CD…